Korean Circ J.  2018 Feb;48(2):168-169. 10.4070/kcj.2018.0006.

Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction

• Park HJ

• KMID: 2403164
• DOI: http://doi.org/10.4070/kcj.2018.0006

Abstract

No abstract available.

MeSH Terms

Diabetes Mellitus*
Myocardial Infarction*

Reference

1. Park HW, Yoon CH, Kang SH, et al. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol. 2013; 169:254–261.

2. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol. 2004; 43:585–591.

3. Park HW, Kang MG, Kim K, et al. Long-term prognosis and clinical characteristics of patients with newly diagnosed diabetes mellitus detected after first acute myocardial infarction: from KAMIR-NIH Registry. Korean Circ J. 2018; 48:134–147.

4. Aguilar D, Solomon SD, Køber L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004; 110:1572–1578.

5. Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW. Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study). Am J Cardiol. 2017; 119:1917–1923.

6. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care. 2016; 39:Suppl 1. S4–S5.

7. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2016; 164:542–552.

8. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58:e44–e122.

9. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013; 368:254–265.

10. Bangalore S, Kumar S, Fusaro M, et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012; 345:e5170.